Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine

Angiogenesis is one of the hallmarks of cancer. Several studies have shown that vascular endothelium growth factor (VEGF) plays a leading role in angiogenesis progression. Antiangiogenic medication has gained substantial recognition and is commonly administered in many forms of human cancer, leading...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Alsaab, Hashem O., Al-Hibs, Alanoud S., Alzhrani, Rami, Alrabighi, Khawlah K., Alqathama, Aljawharah, Alwithenani, Akram, Almalki, Atiah H., Althobaiti, Yusuf S.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7915670/
https://ncbi.nlm.nih.gov/pubmed/33562829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041631
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars